Diligence memo · auto-generated · as of July 2, 2026
NanoMed Pharmaceuticals, Inc.
NanoMed Pharmaceuticals, Inc. has raised $3.0M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
NanoMed Pharmaceuticals, Inc. operates in Pharmaceuticals, based in Kalamazoo.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
NanoMed Pharmaceuticals, Inc. has raised $3.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2006-06-20.
Most recent recorded round closed around 2006-06-20.
Valuation (modeled)modeled
Provath models NanoMed Pharmaceuticals, Inc. at approximately $116M (range $2.3M–$910M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 20.0 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 35% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 57% of those peers.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.